Cargando…
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
INTRODUCTION: Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. METHODS: Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pressure (S...
Autores principales: | Peacock, W Frank, Varon, Joseph, Baumann, Brigitte M, Borczuk, Pierre, Cannon, Chad M, Chandra, Abhinav, Cline, David M, Diercks, Deborah, Hiestand, Brian, Hsu, A, Jois-Bilowich, Preeti, Kaminski, Brian, Levy, Philip, Nowak, Richard M, Schrock, Jon W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219031/ https://www.ncbi.nlm.nih.gov/pubmed/21707983 http://dx.doi.org/10.1186/cc10289 |
Ejemplares similares
-
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial
por: Cannon, Chad M, et al.
Publicado: (2013) -
Considerations for initial therapy in the treatment of acute heart failure
por: Peacock, William F., et al.
Publicado: (2015) -
Inadvertent intrathecal injection of labetalol
por: Verma, S, et al.
Publicado: (2016) -
Correlation of intraventricular nicardipine for refractory vasospasm in aneurysmal subarachnoid hemorrhage with improved neurophysiology on intracranial multimodality monitoring: illustrative case
por: Grandhi, Ramesh, et al.
Publicado: (2022) -
Retrospective evaluation of labetalol as antihypertensive agent in dogs
por: Zublena, Francesco, et al.
Publicado: (2020)